However, while MPO gene deficiency protects against LV dysfunction post-MI [182,183], only one pre-clinical study by Guthoff and colleagues has examined the utility of MPO inhibition in a MI model with reperfusion [187]. The gene discussed is MPO; the disease is myocardial infarction.